XML 25 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated Other Comprehensive Income (Loss), Net of Tax
Interest Rate Swap
Accumulated Other Comprehensive Income (Loss), Net of Tax
Available-for-sale Securities
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2014   28,159,027           1,385,164
Balance at beginning of period at Dec. 31, 2014   $ 28,159 $ 225,015 $ 118,412   $ 508 $ 5,590 $ (11,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)   5,320,000            
Issuance of common stock   $ 5,320 109,569          
Exercise of stock options (in shares)   75,135            
Exercise of stock options   $ 75 1,116          
Issuance of restricted shares (in shares)   71,000            
Issuance of restricted shares   $ 71 (71)          
Forfeitures of restricted shares (in shares)   0            
Forfeitures of restricted shares   $ 0 0          
Share-based compensation     1,485          
Share-based compensation net tax benefit     235          
Net income $ 40,847     40,847        
Dividends on common shares       (6,439)        
Change during period (2,745)         (356) (2,389)  
Purchase of treasury shares (in shares)               28,613
Purchase of treasury shares               $ (732)
Balance at end of period (in shares) at Dec. 31, 2015   33,625,162           1,413,777
Balance at end of period at Dec. 31, 2015 514,759 $ 33,625 337,349 152,820 $ 3,353 152 3,201 $ (12,388)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)   2,549,469            
Issuance of common stock   $ 2,549 69,906          
Exercise of stock options (in shares)   54,510            
Exercise of stock options   $ 55 909          
Issuance of restricted shares (in shares)   155,751            
Issuance of restricted shares   $ 156 (156)          
Forfeitures of restricted shares (in shares)   (7,085)            
Forfeitures of restricted shares   $ (7) 7          
Share-based compensation     2,261          
Share-based compensation net tax benefit     0          
Net income 72,100     72,100        
Dividends on common shares       (10,466)        
Change during period (4,411)         24 (4,435)  
Purchase of treasury shares (in shares)               42,556
Purchase of treasury shares               $ (1,225)
Balance at end of period (in shares) at Dec. 31, 2016   36,377,807           1,456,333
Balance at end of period at Dec. 31, 2016 646,437 $ 36,378 410,276 214,454 (1,058) 176 (1,234) $ (13,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)   2,141,072            
Issuance of common stock   $ 2,141 92,359          
Exercise of stock options (in shares)   132,319            
Exercise of stock options   $ 132 2,537          
Issuance of restricted shares (in shares)   84,147            
Issuance of restricted shares   $ 84 (84)          
Forfeitures of restricted shares (in shares)   (472)            
Forfeitures of restricted shares   $ 0 0          
Share-based compensation     3,316          
Share-based compensation net tax benefit     0          
Net income 73,548     73,548        
Dividends on common shares       (14,883)        
Change during period (222)         116 (338)  
Purchase of treasury shares (in shares)               18,528
Purchase of treasury shares               $ (886)
Balance at end of period (in shares) at Dec. 31, 2017   38,734,873           1,474,861
Balance at end of period at Dec. 31, 2017 $ 804,479 $ 38,735 $ 508,404 $ 273,119 $ (1,280) $ 292 $ (1,572) $ (14,499)